Analysts Set Axon Enterprise, Inc (NASDAQ:AXON) Price Target at $712.75

Axon Enterprise, Inc (NASDAQ:AXON) has been assigned an average rating of “Moderate Buy” from the eighteen research firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $722.1250.

AXON has been the subject of several recent research reports. Morgan Stanley set a $600.00 target price on shares of Axon Enterprise in a report on Thursday, May 7th. UBS Group reduced their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research report on Thursday, May 7th. Piper Sandler reiterated an “overweight” rating and set a $674.00 price objective on shares of Axon Enterprise in a research note on Monday, June 15th. JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Finally, Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th.

Insider Buying and Selling

In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the sale, the insider directly owned 34,024 shares in the company, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the transaction, the insider directly owned 52,813 shares of the company’s stock, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 48,989 shares of company stock worth $24,090,083 over the last quarter. 4.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors and hedge funds have recently made changes to their positions in the company. Czech National Bank lifted its position in Axon Enterprise by 6.8% in the 2nd quarter. Czech National Bank now owns 22,942 shares of the biotechnology company’s stock valued at $12,862,000 after acquiring an additional 1,451 shares in the last quarter. PensionDanmark Pensionsforsikringsaktieselskab increased its holdings in shares of Axon Enterprise by 44.2% in the 2nd quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 11,160 shares of the biotechnology company’s stock worth $6,256,000 after purchasing an additional 3,420 shares in the last quarter. 180 Wealth Advisors LLC increased its holdings in shares of Axon Enterprise by 24.3% in the 2nd quarter. 180 Wealth Advisors LLC now owns 12,655 shares of the biotechnology company’s stock worth $7,095,000 after purchasing an additional 2,474 shares in the last quarter. Quad Cities Investment Group LLC raised its stake in shares of Axon Enterprise by 15.5% in the second quarter. Quad Cities Investment Group LLC now owns 3,182 shares of the biotechnology company’s stock worth $1,784,000 after purchasing an additional 427 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC lifted its holdings in shares of Axon Enterprise by 1.8% during the second quarter. Dynamic Advisor Solutions LLC now owns 2,677 shares of the biotechnology company’s stock valued at $1,501,000 after purchasing an additional 47 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 6.3%

NASDAQ AXON opened at $599.80 on Friday. Axon Enterprise has a twelve month low of $339.01 and a twelve month high of $885.91. The firm has a market capitalization of $48.34 billion, a PE ratio of 240.88, a P/E/G ratio of 13.07 and a beta of 1.38. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The stock’s 50 day moving average is $451.08 and its 200 day moving average is $483.28.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. During the same period last year, the business earned $1.47 EPS. Axon Enterprise’s quarterly revenue was up 33.7% compared to the same quarter last year. Research analysts forecast that Axon Enterprise will post 1.63 earnings per share for the current fiscal year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is benefiting from renewed investor attention around major public-safety contract opportunities, including reported momentum tied to Immigration and Customs Enforcement and a larger Axon-aligned contract, which has helped reinforce the company’s growth narrative. Why Axon Enterprise (AXON) Is Up 14.2% After Trump Stake And New ICE Contract Momentum
• Positive Sentiment: Strong operating results continue to support the stock, with Axon recently posting record quarterly revenue of $807 million and beating EPS expectations, suggesting demand for its public safety technology remains robust. Axon Enterprise (AXON) Following Its Public Safety Platform Narrative Looks Fully Valued
• Positive Sentiment: Analyst commentary is still constructive, with Needham raising its price target to $750 and arguing Axon’s premium valuation is justified by durable booking growth. Needham Bets Axon’s Premium Is Sustainable at $750
• Neutral Sentiment: Some coverage highlights that Axon may already be fully valued after its sharp run-up, which could cap near-term upside even if the long-term story remains strong. Axon Enterprise (AXON) Following Its Public Safety Platform Narrative Looks Fully Valued
• Negative Sentiment: The stock has also faced some pushback from articles noting it underperformed peers and from local political controversy tied to Axon’s role in Scottsdale elections, which may weigh on sentiment. Axon Enterprise Inc. stock underperforms Wednesday when compared to competitors Conservatives challenge Axon’s role in Scottsdale elections

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.